IQVIA PHARMA PRICING & REIMBURSEMENT
The pharmaceutical pricing and reimbursement environment, and market access rules and regulations, are always evolving. With payers and healthcare providers looking for ever-greater value for money, getting the right product to the right patient at the right time is becoming an increasingly complex task.
To make the right decisions, and understand the challenges you could face, you need to stay up to date with all developments that could impact your products. That’s an overwhelming amount of information to gather, understand and react to on a continuous basis.
With regular updates, weekly news alerts, and in-depth annual market snapshots of pricing and reimbursement systems and how they function, IQVIA Pharma Pricing & Reimbursement will give you the insights you need to guide superior decision-making for your portfolio, delivered to you in the form of:
Recent Highlights
In the March 2022 update of IQVIA’s Pharma Pricing & Reimbursement Country Guide series, which provide detailed coverage of the key pricing, reimbursement and market access regulations:
- Learn about amendments to the Medicine Economy Act in Hungary, including changes to the rules for establishing the prices of new drugs seeking reimbursement.
- Find out more about the latest developments regarding the updating of the National List of Essential Medicines (NLEM) in India, postponed as a result of the impact of the coronavirus/COVID-19 pandemic.
- Learn more about the planned purchasing of selected reimbursed out-patient drugs via therapeutic tenders in Norway.
- Get up to date with the latest proposed reform of the Reimbursement Act and the Medical Fund in Poland.
Want to know more about how Pharma Pricing & Reimbursement can help you keep up to date with the latest developments in pricing and reimbursement in 31 key markets around the world?
Fill in the form and we’ll come back to you.
If you are interested in our other pricing and reimbursement intelligence solutions, including IQVIA Pricing Insights, please contact us here.
Best regards,
The Pharma Pricing & Reimbursement Team,
Global Market Insights, IQVIA
Copyright © 2025 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
